Monopar Therapeutics Inc (MNPR) Insider Trading
In the last 90 days, 5 Monopar Therapeutics Inc (MNPR) insiders reported no open-market purchases and 7 sales totaling $4,527,911. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $0.00
- Corporate buyers
- 0
- Latest transaction
- Nov 4, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
MNPR insider trading FAQ
- Are MNPR insiders buying or selling?
- Over the last 90 days, MNPR insiders were net sellers, reporting $0.00 of open-market purchases and $4,527,911 of sales.
- When was the last MNPR insider purchase?
- No open-market insider purchase of Monopar Therapeutics Inc stock was reported in the last 90 days.
- Where does MNPR insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Monopar Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp72 filings
- TWST insider tradingTwist Bioscience Corp30 filings
- NTRA insider tradingNatera Inc28 filings
- ARTV insider tradingArtiva Biotherapeutics Inc20 filings
- RVMD insider tradingRevolution Medicines Inc20 filings
- TEM insider tradingTempus AI Inc20 filings
- CSTL insider tradingCastle Biosciences Inc19 filings
- PACS insider tradingPACS Group Inc.19 filings
